BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


SMALL-CAP WINNERS & LOSERS: UK leisure stocks shaken by variant fears


BATM's Covid-19 PCR tests able to diagnose new Omicron variant


TRADING UPDATES: Halfords ups annual guidance; XPS strikes BT deal


SMALL-CAP WINNERS & LOSERS: Halfords on fast track after guidance lift


TRADING UPDATES: BATM signs new deal; Synectics wins two projects


TRADING UPDATES: IXICO, Spectra and Actual Experience win deals


TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit


IN BRIEF: BATM Advanced Communications wins order from Mexico's Cemex